Search

everythinglearnresearchcommunity

for

Search:↓

Activating the Eda/Edar pathway improves wound healing by enhancing hair follicle growth.

The document concludes that the first book on mesotherapy lacks convincing evidence, the second book is good for beginners in facial rejuvenation, and the third book is valuable for understanding complications in skin surgery.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Scalp injuries and harsh hair care can cause severe hair matting in children.

Drinking kava tea can cause a skin reaction with red, swollen bumps, which may improve with steroids.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

A woman with lupus developed a rare skin condition, which improved with increased medication.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

A patient with zinc depletion improved after zinc supplementation during parenteral nutrition.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Metformin can cause rare severe skin reactions.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.